Trending Now
Software & Data
Tuttnauer Partners with Check Point for Advanced Medical Device Cybersecurity
Check Point Software Technologies Ltd., a renowned provider of AI-powered cybersecurity solutions, has collaborated with Tuttnauer, a global leader in sterilization and infection control equipment, to enhance the security of Tuttnauer's medical devices. Tuttnauer's T-Connect software, utilized in medical and laboratory sterilization devices, now integrates the Check Point Quantum IoT Nano Agent for embedded protection, safeguarding against evolving cyber threats and ensuring end-to-end security for patient data and device integrity...
Medical Devices
GE HealthCare Unveils AI-Powered Ultrasound Systems for Women’s Health Imaging
GE HealthCare has introduced the Voluson Signature 20 and 18 ultrasound systems, designed to revolutionize women's health imaging with advanced AI integration and ergonomic design. These systems promise to accelerate exam times for clinicians while offering clearer imaging of various conditions affecting women's health, boosting diagnostic confidence and treatment decisions...
Consumer Internet
Unveiling The Emotional Potential of Wearable Technology
With approximately 450 million wearable devices shipped in 2023 and a projected 6% annual industry growth, wearable technology has become ubiquitous in daily life. While wearables have revolutionized fitness routines and productivity, questions linger about their true impact on individual lives...
Biotech
Vertex Pharmaceuticals to Acquire Alpine Immune Sciences in $4.9 Billion Deal
Vertex Pharmaceuticals has announced its acquisition of Alpine Immune Sciences for $4.9 billion in cash, representing a 38% premium over Alpine's closing price on April 10, 2024. Alpine, based in Seattle, focuses on developing immunotherapies targeting cancer, kidney disease, and autoimmune and inflammatory conditions through engineered proteins influencing the body's immune response...
Features
The Top 25 Biotech Executives of 2024
The Healthcare Technology Report is pleased to announce The Top 25 Biotech Executives of 2024. This year's awardees and their companies have made vital contributions to innovative new drug development, from cell therapy and genomic analysis to vaccine development, cancer treatment, immune reprogramming, and beyond...